2528. Novel Sources of Administrative Data for Studies of Healthcare Quality
Session: Symposium: Advances in Epidemiology Research Methods
Saturday, October 6, 2018: 2:50 PM
Room: N 24
James Baggs, PhD, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA

James Baggs received his doctoral degree from the Rollins School of Public Health at Emory University in 1999. During his doctoral training, Dr. Baggs concentrated on studies of HIV genetic variation. After receiving his degree, Dr. Baggs worked as an epidemiologist for the State of Washington. Within that position, Dr. Baggs concentrated on developing surveillance activities and epidemiological studies of occupational injuries and illness in Washington State. In 2001, Dr. Baggs returned to the Centers for Disease Control and Prevention in Atlanta, GA as an epidemiologist in the Immunization Safety Office on the Vaccine Safety Datalink (VSD) project. Within the VSD, he participated as both a data manager and an epidemiologist and was involved in the continuing development of the VSD, its distributed data model, and the development of active surveillance in near real time as well as working on a number of research studies within the VSD. In 2010, Dr. Baggs moved to the Office of Prevention Research and Evaluation (OPRE) within the Division of Healthcare Quality Promotion. At OPRE, Dr. Baggs concentrated on developing and conducting studies to investigate research questions regarding healthcare associated infections (HAI) utilizing existing data sources and large administrative data sources. In 2017, Dr. Baggs accepted the position of team leader for the Data Science and Analytics team within OPRE. Throughout his career, Dr. Baggs has participated as a co-author on a number of peer reviewed publications involving HIV, immunization safety, healthcare-associated infections, antibiotic stewardship, and the use of administrative data in epidemiologic research.


J. Baggs, None

<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.